SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-23-002868
Filing Date
2023-05-04
Accepted
2023-05-04 08:32:12
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cmpx20230331_10q.htm   iXBRL 10-Q 764565
2 EXHIBIT 31.1 ex_506857.htm EX-31.1 14688
3 EXHIBIT 31.2 ex_506858.htm EX-31.2 14702
4 EXHIBIT 32.1 ex_506859.htm EX-32.1 7204
5 EXHIBIT 32.2 ex_506860.htm EX-32.2 7242
  Complete submission text file 0001171843-23-002868.txt   4154367

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20230331.xsd EX-101.SCH 38142
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20230331_cal.xml EX-101.CAL 31597
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20230331_def.xml EX-101.DEF 245222
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20230331_lab.xml EX-101.LAB 228121
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20230331_pre.xml EX-101.PRE 273192
52 EXTRACTED XBRL INSTANCE DOCUMENT cmpx20230331_10q_htm.xml XML 675896
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 23886710
SIC: 2836 Biological Products, (No Diagnostic Substances)